Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||
| Net Income | -24,953 | 0 | -10,762 |
| Depreciation Amortization | 1 | 0 | N/A |
| Income taxes - deferred | -182 | N/A | N/A |
| Accounts payable and accrued liabilities | 228 | N/A | N/A |
| Other Working Capital | 1,422 | 0 | 762 |
| Other Operating Activity | 18,949 | 0 | 10,000 |
| Operating Cash Flow | $-4,535 | $0 | $0 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -7 | 0 | N/A |
| Other Investing Activity | 0 | 0 | -5,000 |
| Investing Cash Flow | $-7 | $0 | $-5,000 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 336,893 | N/A | 5,000 |
| Other Financing Activity | -1,282 | 0 | 0 |
| Financing Cash Flow | $335,611 | $0 | $5,000 |
| End Cash Position | 331,069 | 0 | N/A |
| Net Cash Flow | $331,069 | $0 | $0 |
| Free Cash Flow | |||
| Operating Cash Flow | -4,535 | 0 | 0 |
| Capital Expenditure | -7 | N/A | N/A |
| Free Cash Flow | -4,542 | 0 | 0 |